Emerging Nanotechnology in Chronic Respiratory Diseases-Reference-Cited by-同舟云学术

Emerging Nanotechnology in Chronic Respiratory Diseases

Published:2020 Issue: Volume: Page:449-468
ISSN:
Container-title:Nanoformulations in Human Health
language:
Short-container-title:

Author:

Pandey Parijat,Mehta Meenu,Shukla Shakti,Wadhwa Ridhima,Singhvi Gautam,Chellappan Dinesh Kumar,Satija Saurabh,Gupta Gaurav,Awasthi Rajendra,Prasher Parteek,Hansbro Philip M.,Dua Kamal,Dureja Harish

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-41858-8_20

Reference131 articles.

1. Abdelaziz HM, Gaber M, Abd-Elwakil MM, Mabrouk MT, Elgohary MM, Kamel NM, Elzoghby AO (2018) Inhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregates. J Control Release 269:374–392

2. Abdelaziz HM, Elzoghby AO, Helmy MW, Samaha MW, Fang JY, Freag MS (2019) Liquid crystalline assembly for potential combinatorial chemo–herbal drug delivery to lung cancer cells. Int J Nanomedicine 14:499–507

3. Abu-Dahab R, Schäfer UF, Lehr CM (2001) Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion. Eur J Pharm Sci 14(1):37–46

4. Adam B, Nicolas T, Ilaria A, Anais C, Camilla F, Claudine D, Elias F (2017) Anti-inflammatory effect of anti-TNF-α SiRNA cationic phosphorus dendrimer nanocomplexes administered intranasally in a murine acute lung injury model. Biomacromolecules 18(8):2379–2388

5. Agustí A, Celli B (2017) Natural history of COPD: gaps and opportunities. ERJ Open Res 3(4):1–10

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Calcitriol Treated Mesenchymal Stem Cells as an Immunomodulation Micro-environment on Allergic Asthma in a Mouse Model;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-07

2. PAMAM dendrimers and prospects of their application in medicine;Medicine of Extreme Situations;2022-03

3. Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases;Future Medicinal Chemistry;2022-02

4. Solid-Lipid Nanocarriers (SLNs)-Based Drug Delivery for Treating Various Pulmonary Diseases;Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases;2022

5. The emerging potential of SIRT-3 in oxidative stress-inflammatory axis associated increased neuroinflammatory component for metabolically impaired neural cell;Chemico-Biological Interactions;2021-01